Comparing Hypertension Remote Monitoring Evaluation Redesign
CHARMED
1 other identifier
interventional
2,500
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effectiveness of evidence-based, adapted, and tailored, patient-focused and clinic-focused strategies to improve blood pressure (BP) control in English- and Spanish-speaking patients with hypertension (HTN).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Oct 2024
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2023
CompletedFirst Posted
Study publicly available on registry
November 2, 2023
CompletedStudy Start
First participant enrolled
October 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
January 23, 2026
January 1, 2026
3.4 years
October 27, 2023
January 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in systolic BP (clinic)
Clinic-based BP readings in EHR
Baseline, 6 months
Secondary Outcomes (5)
Change in systolic BP (home)
Baseline, 6 months
Patient activation and satisfaction
Baseline, 6 months
Number of participants with BP control
Baseline, 6 months
Medication intensification when BP is uncontrolled
Baseline, 6 months
Patient-reported medication adherence
Baseline, 6 months
Study Arms (4)
Standard and One-time Training
ACTIVE COMPARATORPatient level: Standard, automatic reminders Clinic level: One-time training
Standard and Practice Facilitation
EXPERIMENTALPatient level: Standard, automatic reminders Clinic level: Regular, ongoing coaching
High-intensity and One-time Training
EXPERIMENTALPatient level: Personalized feedback Clinic level: One-time training
High-intensity and Practice Facilitation
EXPERIMENTALPatient level: Personalized feedback Clinic level: Regular, ongoing coaching
Interventions
Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.
Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.
Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.
Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.
Eligibility Criteria
You may qualify if:
- years or older
- Any sex/gender
- Any race or ethnicity
- Have hypertension or high blood pressure (BP) (BP \>=140/90 mmHg at least twice in the previous 18 months)
- Can read and write English or Spanish
- Be able to provide consent
You may not qualify if:
- We will exclude individuals with conditions that might have severe self-management limitations due to a disability or medical condition or might complicate remote BP monitoring, such as self-reported:
- Pregnancy
- Lactating/nursing
- Dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
Related Publications (2)
Tieu L, Khoong EC, Shah ND, Gosdin MM, Wang SJ, Sharma A, Abtahi N, Stern RJ, Zhou C, Sarkar U, Lyles CR; CHARMED Consortium. Applying behavior change theory to intervention design: promoting clinic-level implementation of self-measured blood pressure monitoring in safety net primary care settings. Transl Behav Med. 2026 Jan 7;16(1):ibaf094. doi: 10.1093/tbm/ibaf094.
PMID: 41723583DERIVEDLyles CR, Khoong EC, Stern RJ, Abtahi N, Sharma AE, Pletcher MJ, Xia F, Garcia F, Shah ND, Tieu L, Sarkar U; CHARMED consortium. Championing Hypertension Remote Monitoring for Equity and Dissemination (CHARMED): A multi-site factorial randomized controlled trial protocol. Contemp Clin Trials. 2025 May;152:107879. doi: 10.1016/j.cct.2025.107879. Epub 2025 Mar 12.
PMID: 40086748DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Urmimala Sarkar
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2023
First Posted
November 2, 2023
Study Start
October 21, 2024
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share